GGrantIndex
Sort

172,184 grants matching inflammation

Role of pannexin-1 hemichannels in NeuroAIDS

$720,109
Eliseo A Eugenin · Rbhs-New Jersey Medical School · R01 · FY2017 · NS

Gut Microbiota-Mediated Inflammatory Interactions Between Alcohol Use Disorders and HIV Infection

$720,080
Ali Keshavarzian · Rush University Medical Center · R01 · FY2025 · AA

Dissect the mechanisms of selective regional vulnerability in Lewy Body Dementias via comparative snRNA-seq analysis

$720,071
Guoyan Zhao · Washington University · R01 · FY2025 · NS

Dissect the mechanisms of selective regional vulnerability in Lewy Body Dementias via comparative snRNA-seq analysis

$720,071
Guoyan Zhao · Washington University · R01 · FY2023 · NS

Dissect the mechanisms of selective regional vulnerability in Lewy Body Dementias via comparative snRNA-seq analysis

$720,071
Guoyan Zhao · Washington University · R01 · FY2024 · NS

Caregivers as the Agent of Change for Childhood Obesity and Chronic Disease Risk Among Latino Families

$720,068
Kerri N Boutelle · Children'S Hospital Of Los Angeles · P50 · FY2025 · MD

Low Density Neutrophils Link Inflammation and Coagulopathy in COVID-19

$720,048
Jun Yan · University Of Louisville · R01 · FY2025 · HL

Frailty and patient centered outcomes in candidates for lung transplantation

$720,039
Jonathan Paul Singer · University Of California, San Francisco · R01 · FY2020 · HL

Anti-Inflammatory Lipid Mediators in Asthma

$720,022
Bruce A Freeman · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · HL

Increasing biocompatibility of stents via CD47 surface functionalization: Mechanistic and Preclinical studies

$720,017
Stanley Joseph Stachelek · Children'S Hosp Of Philadelphia · R01 · FY2019 · EB

Increasing biocompatibility of stents via CD47 surface functionalization: Mechanistic and Preclinical studies

$720,017
Stanley Joseph Stachelek · Children'S Hosp Of Philadelphia · R01 · FY2018 · EB

Multilevel Forms of Structural Racism and Racial Inequalities in ADRD Risk

$720,008
Chantel L. Martin · Univ Of North Carolina Chapel Hill · R01 · FY2022 · AG

Early-life bisphenol A, immune dysregulation, and inner-city pediatric asthma

$720,000
Robin Marjorie Whyatt · Columbia University Health Sciences · RC2 · FY2009 · ES

IDENTIFICATION OF LIPID BIOMARKERS OF INFLAMMATION AND METABOLIC DISTRURBANCES IN GWI

$720,000
The Roskamp Institute, Inc. · · FY2016 · Department of the Army

Early-life bisphenol A, immune dysregulation, and inner-city pediatric asthma

$720,000
Robin Marjorie Whyatt · Columbia University Health Sciences · RC2 · FY2010 · ES

Tailoring Novel Therapeutics for Emerging Drug-Resistant C. Difficile Colitis

$719,987
Richard L Guerrant · University Of Virginia · U01 · FY2011 · AI

Microbial ecology of the inflamed intestine

$719,973
Brian M Ahmer · Ohio State University · R01 · FY2018 · AI

Southern California Children's Enviromental Health Center (SC-CEHC)

$719,938
Rob S McConnell · University Of Southern California · P01 · FY2016 · ES

Novel medical adjunctive therapy to catheter ablation for atrial fibrillation

$719,937
Jeffrey J Goldberger · University Of Miami School Of Medicine · R01 · FY2021 · HL

Translational Studies of Age-Associated Arterial Dysfunction, Western Diet and Aerobic Exercise: Role of the Gut Microbiome

$719,929
Douglas R Seals · University Of Colorado · R01 · FY2020 · HL

Effect of buprenorphine on monocytes in the context of neuroAids and opioid abuse

$719,921
Joan Weinberger Berman · Albert Einstein College Of Medicine · R01 · FY2020 · DA

Sleep Apnea in TIA: Reducing Cardiovascular Risk with Positive Airway Pressure

$719,917
Henry Klar Yaggi · Yale University · U34 · FY2010 · HL

Development of 11C-PABA as a bacteria-specific imaging agent for spinal infections

$719,894
David M Wilson · University Of California, San Francisco · R01 · FY2020 · EB

Pulmonary Immune Regulation of Lung Injury after Pediatric Hematopoietic Cell Transplant

$719,882
Matthew Scott Zinter · University Of California, San Francisco · R01 · FY2025 · HL

PSMA’s enzymatic activity as new target for Prostate Cancer diagnosis and therapy

$719,857
Jan Grimm · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA